We are live on ! Find out more
KALV

KalVista Pharmaceuticals

Delisted

KALV was delisted on the 10th of June, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
VA
1
VR Adviser
New York
$82M
TCM
2
Tang Capital Management
California
$61.4M +$1.38M +100,000 +2%
FLSM
3
Frazier Life Sciences Management
California
$61.4M +$2.1M +152,000 +3%
SCM
4
Suvretta Capital Management
New York
$58.1M -$2.57M -186,288 -4%
Capital World Investors
5
Capital World Investors
California
$38.7M
BlackRock
6
BlackRock
New York
$38.1M -$46.7K -3,377 -0.1%
Vanguard Group
7
Vanguard Group
Pennsylvania
$30.5M +$1.23M +88,720 +4%
Millennium Management
8
Millennium Management
New York
$25.5M +$24.3M +1,755,594 +515%
WP
9
Woodline Partners
California
$23.4M
Goldman Sachs
10
Goldman Sachs
New York
$21.9M +$23M +1,665,783 +1,239%
PHP
11
Parkman Healthcare Partners
Connecticut
$21.1M +$14.6M +1,055,940 +155%
State Street
12
State Street
Massachusetts
$19.2M +$3.12M +225,957 +17%
SCM
13
Silverarc Capital Management
Massachusetts
$16.6M -$6.48M -468,793 -26%
EA
14
Emerald Advisers
Pennsylvania
$16.5M +$4.33M +313,205 +30%
OCA
15
Octagon Capital Advisors
New York
$15.5M
Schroder Investment Management Group
16
Schroder Investment Management Group
United Kingdom
$14.1M +$8.34M +603,499 +109%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$11.3M -$173K -12,541 -1%
EMFAT
18
Emerald Mutual Fund Advisers Trust
Pennsylvania
$11.2M +$2.06M +149,003 +19%
VPC
19
Vestal Point Capital
New York
$9.13M -$54.2M -3,925,000 -84%
FGP
20
Freestone Grove Partners
California
$8.58M +$9.73M +704,448 New
SCM
21
Sio Capital Management
New York
$8.33M +$9.45M +683,819 New
KCM
22
Kynam Capital Management
New Jersey
$7.38M +$8.38M +606,171 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$7.27M +$6.75M +488,839 +454%
Barclays
24
Barclays
United Kingdom
$7.04M +$5.65M +408,981 +242%
Morgan Stanley
25
Morgan Stanley
New York
$6.88M +$4.49M +325,227 +136%